Janux Therapeutics, Inc. (JANX) Total liabilities 2020–2025
Janux Therapeutics, Inc. (JANX) total liabilities at each fiscal year-end, per SEC filings.
$44.7MFY2025 · since FY2020: $9.2M → $44.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $44.7M | +15.5% |
| FY2024 | $38.7M | +7.4% |
| FY2023 | $36.1M | -16.7% |
| FY2022 | $43.3M | +220.6% |
| FY2021 | $13.5M | +46.2% |
| FY2020 | $9.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice